Jun Bie
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Surgery top 10%
- Esophageal Cancer Research and Treatment
Papers in
-
- Cancer, Hypoxia, and Metabolism 2
- Cancer, Lipids, and Metabolism 2
- MicroRNA in disease regulation 2
- Oncology 8
- Cancer Cells and Metastasis 3
- Co-authors
- Guohui Xu (2 shared papers)Mi Yang (2 shared papers)Xinping Zhang (2 shared papers)Ziwei Wang (1 shared paper)Li Deng (1 shared paper)Xiaocong Xiang (1 shared paper)Veerle Van Hoeck (1 shared paper)Dongqin Xiao (1 shared paper)
In The Last Decade
Jun Bie
21 papers receiving 682 citations
Jun Bie's Hit Papers
Peers
Comparison fields: 5 of 52
- Oncology 230
- Surgery 333
- Pulmonary and Respiratory Medicine 128
- Cancer Research 47
- Immunology 35
Countries citing papers authored by Jun Bie
This map shows the geographic impact of Jun Bie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Bie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Bie more than expected).
Fields of papers citing papers by Jun Bie
This network shows the impact of papers produced by Jun Bie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Bie. The network helps show where Jun Bie may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Bie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma Hit paper breakdown → | 2021 | 558 |
| 2 | 2015 | 32 | |
| 3 | 2019 | 17 | |
| 4 | 2017 | 15 | |
| 5 | 2021 | 15 | |
| 6 | 2020 | 13 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 6 | |
| 9 | 2021 | 6 | |
| 10 | 2019 | 4 | |
| 11 | 2021 | 3 | |
| 12 | 2024 | 1 | |
| 13 | 2024 | 1 | |
| 14 | 2016 | 1 | |
| 15 | Surgery or radiotherapy, which is more effective for upper esophageal carcinoma? A retrospective cohort study based on 191 cases | 2019 | 1 |
| 16 | 2023 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 1 |
About Jun Bie
Jun Bie is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Surgery, having authored 24 papers that have together received 689 indexed citations. Recurring topics across this work include Circular RNAs in diseases (3 papers), RNA modifications and cancer (3 papers), Cancer Cells and Metastasis (3 papers), Lung Cancer Treatments and Mutations (2 papers), Esophageal Cancer Research and Treatment (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer, Lipids, and Metabolism (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Oncology (230 citations), Surgery (333 citations), Pulmonary and Respiratory Medicine (128 citations), Cancer Research (47 citations) and Immunology (35 citations). Jun Bie has collaborated with scholars based in China, Belgium and Spain. Frequent co-authors include Guohui Xu, Mi Yang, Xinping Zhang, Ziwei Wang, Li Deng, Xiaocong Xiang, Veerle Van Hoeck, Dongqin Xiao, Jo Leroy and Chunlei Yu. Their work appears in journals such as Frontiers in Public Health, Cell Biochemistry and Biophysics, Journal of Advanced Research, Oncology Reports and Molecular Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.